THE Australasian College of Pharmacy is informing pharmacists that the current ATAGI guidance advises that all adults who have had their last COVID-19 vaccine dose or confirmed infection (whichever is the most recent) six months ago or longer are eligible for a 2023 COVID-19 Booster dose.
Pharmacists are reminded that in 2023, Bivalent mRNA vaccines are the preferred option for booster doses.
Moderna is also sponsoring a new educational module called Bivalent COVID-19 Vaccines.
This activity has been accredited for one hour of Group one CPD (or one CPD credit), suitable for inclusion in an individual pharmacist's CPD plan, which can be converted to one hour of Group two CPD (or two CPD credits) upon successful activity completion.
Learn more HERE.
Register for the module HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 May 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 May 23
